These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A partially degraded form of human plasminogen in circulating blood. Yamamoto J; Okamoto U; Kojima S; Morita S; Fujii K Clin Lab Haematol; 1982; 4(2):117-30. PubMed ID: 6214361 [TBL] [Abstract][Full Text] [Related]
25. Studies on blood coagulation and fibrinolysis in conditions associated with an increased incidence of thrombosis. Methodological and clinical investigations. Ygge J Scand J Haematol Suppl; 1970; 11():1-45. PubMed ID: 5270655 [No Abstract] [Full Text] [Related]
26. A method to correct for the continuing activation during the second stage in a two-stage assay. Exemplified by urokinase activation of plasminogen determined by the lysis time method. Berg W Thromb Diath Haemorrh; 1968 Mar; 19(1):161-8. PubMed ID: 4231459 [No Abstract] [Full Text] [Related]
27. [Effect of the enzyme preparation longolytin on fibrinolysis in animals]. Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406 [TBL] [Abstract][Full Text] [Related]
28. Changes in plasma fibrinolytic activity in guinea-pigs exposed to linear acceleration in acute and chronic experiments. Cananău SA; Dumitrescu-Papahagi E; Groza P Rev Roum Physiol; 1973; 10(6):441-9. PubMed ID: 4272338 [No Abstract] [Full Text] [Related]
30. [Studies on the standardization of fibrinolysis tests. II. Clinical significance of determination of fibrinolytic factors and its interpretation (author's transl)]. Egawa H; Hashimoto S; Suzuki K Rinsho Byori; 1979 Mar; 27(3):250-6. PubMed ID: 155750 [No Abstract] [Full Text] [Related]
31. [The fibrinolytic activity in human saliva (author's transl)]. Sasaki Y; Horiuchi K; Kitano S Josai Shika Daigaku Kiyo; 1978; 7(1):163-6. PubMed ID: 228779 [No Abstract] [Full Text] [Related]
32. [Value of various coagulation studies in the diagnosis of thromboses]. Kuzin MI; Bokarev IN; Smolianitskiĭ AIa; Shumbalina LF; Dreĭzina AM Kardiologiia; 1974 Nov; 14(11):85-9. PubMed ID: 4279311 [No Abstract] [Full Text] [Related]
33. [Fibrinolysis of pleural exudates]. Blatný J; Oral I Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):39-42. PubMed ID: 4244001 [No Abstract] [Full Text] [Related]
34. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. Wiman B; Wallén P Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055 [No Abstract] [Full Text] [Related]
35. [Enzymatic and nonenzymatic fibrinolysis in various kidney diseases]. Sokratov NV Ter Arkh; 1983; 55(6):55-8. PubMed ID: 6193598 [No Abstract] [Full Text] [Related]
36. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro]. Golubenkova NI Lab Delo; 1981; (12):720-2. PubMed ID: 6172641 [No Abstract] [Full Text] [Related]
37. [The biochemistry of fibrinolytic system of blood serum]. Wolosowicz N; Jaroszewicz L; Niewiarowski S Postepy Biochem; 1968; 14(1):3-25. PubMed ID: 4232584 [No Abstract] [Full Text] [Related]
38. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Hedner U; Nilsson IM; Jacobsen CD Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664 [No Abstract] [Full Text] [Related]
39. [Fibrinolysis]. Levy G; Michault A; Jamet M Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114 [TBL] [Abstract][Full Text] [Related]
40. [Value of determining complex heparin compounds for early diagnosis and evaluation of the degree of severity of late pregnancy toxemia]. Zakharova TP Akush Ginekol (Mosk); 1986 Apr; (4):57-9. PubMed ID: 2940925 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]